PB1762: PONATINIB VERSUS IMATINIB WITH REDUCED-INTENSITY CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PHALLCON STUDY

Bibliographic Details
Main Authors:	E. Jabbour, G. Martinelli, M. Vignetti, H. Kantarjian, D. Gomez-Almaguer, Y. Minami, H. Dombret, M. Hennessy, A. Vorog, B. Wang, J.-M. Ribera
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000849904.09812.c6

Internet